Background Background Membrane phospholipid
Membrane phospholipid and high-energy abnormalities measured and high-energy abnormalities measured with phosphorus magnetic resonance with phosphorus magnetic resonance spectroscopy ( spectroscopy ( 31 31 P^MRS) have been P^MRS) have been reported in patients with schizophrenia in reported in patients with schizophrenia in several brain regions. several brain regions.
Aims Aims Using improved imaging
Using improved imaging techniques, previously inaccessible brain techniques, previously inaccessible brain regions were examined in patients with regions were examined in patients with first-episode schizophrenia and healthy first-episode schizophrenia and healthy volunteers with 4.0 T volunteers with 4.0 T 31 31 P^MRS. P^MRS.
Method
Method Brain spectra were collected Brain spectra were collected in vivo in vivo from15 patients with first-episode from15 patients with first-episode schizophrenia and15 healthy volunteers schizophrenia and15 healthy volunteers from15 cm from15 cm 3 3 effective voxels in the effective voxels in the thalamus, cerebellum, hippocampus, thalamus, cerebellum, hippocampus, anterior/posterior cingulate, prefrontal anterior/posterior cingulate, prefrontal cortex and parieto-occipital cortex. cortex and parieto-occipital cortex.
Results

Results People with first-episode
People with first-episode schizophrenia showed increased levels of schizophrenia showed increased levels of glycerophosphocholine in the anterior glycerophosphocholine in the anterior cingulate.Inorganic phosphate, phosphocingulate.Inorganic phosphate, phosphocreatine and adenosine triphosphate creatine and adenosine triphosphate concentrations were also increased in the concentrations were also increased in the anterior cingulate in this group. anterior cingulate in this group.
Conclusions Conclusions The increased
The increased phosphodiester and high-energy phosphodiester and high-energy phosphate levels in the anterior cingulate phosphate levels in the anterior cingulate of brains of people with first-episode of brains of people with first-episode schizophrenia may indicate neural schizophrenia may indicate neural overactivity in this region during the early overactivity in this region during the early stages of the illness, resulting in increased stages of the illness, resulting in increased excitotoxic neural membrane breakdown. excitotoxic neural membrane breakdown.
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Schizophrenia may arise from abnormal Schizophrenia may arise from abnormal functioning of the prefrontal cortex, functioning of the prefrontal cortex, anterior cingulate, thalamus, cerebellum anterior cingulate, thalamus, cerebellum and hippocampus, along with the neuroand hippocampus, along with the neuronal circuitry connecting these brain nal circuitry connecting these brain regions (Lipska & Weinberger, 1993; regions (Lipska & Weinberger, 1993; Jones, 1997; Benes, 1998; Selemon & Jones, 1997; Benes, 1998; Selemon & Goldman-Rakic, 1999) . Goldman-Rakic, 1999) . In vivo
In vivo 31-phos-31-phosphorus magnetic resonance spectroscopy phorus magnetic resonance spectroscopy ( ( 31 31 P-MRS; Williamson & Drost, 1999) P-MRS; Williamson & Drost, 1999 ) measures levels of energy metabolites: measures levels of energy metabolites: phosphocreatine, inorganic phosphate phosphocreatine, inorganic phosphate and adenosine triphosphate; it also and adenosine triphosphate; it also measures constituents of membrane measures constituents of membrane synthesis -phosphomonoesters (phosphosynthesis -phosphomonoesters (phosphoethanolamine and phosphocholine) -and ethanolamine and phosphocholine) -and breakdown phosphodiesters (glycerobreakdown phosphodiesters (glycerophosphoethanolamine and glycerophosphoethanolamine and glycerophosphocholine). An earlier phosphocholine). An earlier 31 31 P-MRS P-MRS study (Williamson & Drost, 1999) study (Williamson & Drost, 1999) examining patients with first-episode examining patients with first-episode schizophrenia demonstrated decreased schizophrenia demonstrated decreased phosphomonoester and increased phosphosphomonoester and increased phosphodiester levels in the prefrontal regions. phodiester levels in the prefrontal regions. Findings in medicated patients with Findings in medicated patients with chronic illness have been inconsistent chronic illness have been inconsistent (Williamson & Drost, 1999) . With (Williamson & Drost, 1999) . With optimised optimised 31 31 P-MRS three-dimensional P-MRS three-dimensional chemical shift imaging at 4 Tesla, we chemical shift imaging at 4 Tesla, we obtained adequate spectral and spatial obtained adequate spectral and spatial resolution to measure individual metaboresolution to measure individual metabolites involved in energy or membrane lites involved in energy or membrane metabolism from small voxels (15 cm metabolism from small voxels (15 cm 3 3 ) ) in vivo in vivo (Jensen (Jensen et al et al, 2002 (Jensen et al et al, , 2002a . Our hypoth-). Our hypothesis was that increased membrane breakesis was that increased membrane breakdown occurs in the anterior cingulate of down occurs in the anterior cingulate of people with first-episode schizophrenia people with first-episode schizophrenia (compared with controls), consistent with (compared with controls), consistent with the increased glutamate-mediated activity the increased glutamate-mediated activity seen with proton MRS ( seen with proton MRS ( 1 1 H-MRS) in such H-MRS) in such patients (Theberge patients (Theberge et al et al, 2002) . The , 2002) . The hypothesis also predicts decreased memhypothesis also predicts decreased membrane metabolite levels in hippocampal, brane metabolite levels in hippocampal, thalamic and cerebellar regions, consistent thalamic and cerebellar regions, consistent with neurodevelopmental abnormalities with neurodevelopmental abnormalities (Lipska & Weinberger, 1993; Jones, (Lipska & Weinberger, 1993; Jones, 1997) . 1997).
METHOD METHOD Participants Participants
Fifteen patients with first-episode schizoFifteen patients with first-episode schizophrenia and 15 healthy volunteers of phrenia and 15 healthy volunteers of comparable age, gender, handedness and comparable age, gender, handedness and parental educational level (Table 1) , rated parental educational level (Table 1) , rated as in our previous study (Jensen as in our previous study (Jensen et al et al, , 2002 (Jensen et al et al, , 2002b , participated in the study after ), participated in the study after giving informed, written consent according giving informed, written consent according to the guidelines of the Health Sciences to the guidelines of the Health Sciences Research Ethics Board at the University of Research Ethics Board at the University of Western Ontario. The DSM-IV diagnosis Western Ontario. The DSM-IV diagnosis of schizophrenia (American Psychiatric of schizophrenia (American Psychiatric Association, 1994) was established using Association, 1994) was established using the Structured Clinical Interview for the Structured Clinical Interview for DSM-IV (SCID; First DSM-IV (SCID; First et al et al, 1997) , adminis-, 1997), administered by a psychiatrist (P.C.W.). Twelve tered by a psychiatrist (P.C.W.). Twelve cases were classified as having paranoid cases were classified as having paranoid schizophrenia and three as having undifferschizophrenia and three as having undifferentiated schizophrenia. Ten patients were entiated schizophrenia. Ten patients were neuroleptic-naıve, but three of the ten had neuroleptic-naïve, but three of the ten had received a benzodiazepine for sedation at received a benzodiazepine for sedation at the time of the scan and another three had the time of the scan and another three had been previously exposed to a selective serobeen previously exposed to a selective serotonin reuptake inhibitor. Of the five tonin reuptake inhibitor. Of the five patients receiving neuroleptic medication patients receiving neuroleptic medication at the time of the scan, four were taking at the time of the scan, four were taking atypical antipsychotic agents and one a atypical antipsychotic agents and one a conventional neuroleptic, with two patients conventional neuroleptic, with two patients having had prior exposure to a selective having had prior exposure to a selective serotonin reuptake inhibitor. The estimated serotonin reuptake inhibitor. The estimated mean duration of exposure to antipsychotic mean duration of exposure to antipsychotic medication at the time of scanning for the medication at the time of scanning for the five patients was 0. (Norman & Malla, 2001 ). The healthy volunteers were recruited from the comvolunteers were recruited from the community by advertisement and were assessed munity by advertisement and were assessed by a psychiatrist (P.C.W.) using the SCID by a psychiatrist (P.C.W.) using the SCID to exclude psychiatric diagnoses or a to exclude psychiatric diagnoses or a history of psychiatric disorders in a firsthistory of psychiatric disorders in a firstor second-degree relative. No patient or or second-degree relative. No patient or volunteer had a history of head injury or volunteer had a history of head injury or of drug or alcohol misuse in the 2 years of drug or alcohol misuse in the 2 years before the scan, or had any current serious before the scan, or had any current serious medical illness. medical illness.
Imaging technique Imaging technique
All experiments were performed on a All experiments were performed on a 4.0 Tesla Varian/Siemens/Unity Inova 4.0 Tesla Varian/Siemens/Unity Inova whole-body magnetic resonance scanner whole-body magnetic resonance scanner 31 P voxel position-P voxel positioning (repetition time 11 ms, echo time 6 ms, ing (repetition time 11 ms, echo time 6 ms, 256 phase-encodes, 0.93 mm 256 phase-encodes, 0.93 mm6 60.93 mm 0.93 mm pixels). Thirty-two pixels). Thirty-two T T 1 1 -weighted transverse -weighted transverse images were acquired on the brain using a images were acquired on the brain using a magnetisation-prepared (adiabatic invermagnetisation-prepared (adiabatic inversion pulse 0.5 s prior to data collection) sion pulse 0.5 s prior to data collection) three-dimensional fast low angle shot three-dimensional fast low angle shot imaging sequence (repetition time 11 ms, imaging sequence (repetition time 11 ms, echo time 6.2 ms, total acquisition time echo time 6.2 ms, total acquisition time 5 53 min) with a nominal slice 3 min) with a nominal slice thickness of thickness of 4.375 mm and 1.09 4.375 mm and 1.096 61.09 mm 1.09 mm in-plane in-plane resolution. These images were used to resolution. These images were used to calculate grey matter, white matter and calculate grey matter, white matter and cerebrospinal fluid ratios in the cerebrospinal fluid ratios in the Image segmentation and partial Image segmentation and partial volume estimation volume estimation
The transverse image data-set for each The transverse image data-set for each brain examined was first separated into brain examined was first separated into three distinct binary tissue maps -grey three distinct binary tissue maps -grey matter, white matter and cerebrospinal matter, white matter and cerebrospinal fluid -by thresholding the original highfluid -by thresholding the original highcontrast image set. Two thresholding values contrast image set. Two thresholding values were obtained from the central slice of each were obtained from the central slice of each image set, which best displayed the ventriimage set, which best displayed the ventricles, corpus callosum and grey matter of cles, corpus callosum and grey matter of the anterior cingulate. The thresholding the anterior cingulate. The thresholding coefficients were then varied until each coefficients were then varied until each segmented image type matched the corresegmented image type matched the corresponding anatomy in the original reference sponding anatomy in the original reference image. The thresholding values differed image. The thresholding values differed between the individuals examined since between the individuals examined since image signal intensity depended on receiver image signal intensity depended on receiver gain and coil loading. Extraneous tissue gain and coil loading. Extraneous tissue with signal intensities similar to neural with signal intensities similar to neural tissue or cerebrospinal fluid, such as skin tissue or cerebrospinal fluid, such as skin and subcutaneous lipid, was removed from and subcutaneous lipid, was removed from the segmented images using commercial the segmented images using commercial software (Analyze 4.0 for PC; Biomedical software (Analyze 4.0 for PC; Biomedical Imaging Resources, Mayo Clinic) to avoid Imaging Resources, Mayo Clinic) to avoid it being counted as neuronal tissue in the it being counted as neuronal tissue in the final volumetric analysis. To obtain the final volumetric analysis. To obtain the tissue ratio contribution for each tissue ratio contribution for each 31 31 P region P region of interest, the three segmented image dataof interest, the three segmented image datasets were convolved with the calculated sets were convolved with the calculated three-dimensional point spread function of three-dimensional point spread function of the the 31 31 P chemical shift imaging acquisition P chemical shift imaging acquisition (Jensen (Jensen et al et al, 2002 (Jensen et al et al, , 2002a . The partial volume ). The partial volume contribution for each tissue type was then contribution for each tissue type was then expressed as a percentage of total tissue expressed as a percentage of total tissue contribution for each region of interest contribution for each region of interest (see Table 3 ). (see Table 3 ).
In vivo In vivo 31 31 P^MRS P^MRS
Once the Once the 1 1 H shimming and imaging were H shimming and imaging were completed, the completed, the 1 1 H head coil was manually H head coil was manually replaced with a single-tuned, replaced with a single-tuned, 31 31 P quadra-P quadrature, 14 cm long birdcage head coil, with ture, 14 cm long birdcage head coil, with the person to be examined still in place in the person to be examined still in place in the Plexiglas cradle inside the magnet. the Plexiglas cradle inside the magnet. Previous phantom experiments verified that Previous phantom experiments verified that manual coil replacement did not affect the manual coil replacement did not affect the shim. A shim. A 31 31 P external reference standard -P external reference standardmethylene diphosphonic acid, 270 mol/l, methylene diphosphonic acid, 270 mol/l, T T 1 1 at 4.0 Tesla about 6 s -was fastened to at 4.0 Tesla about 6 s -was fastened to the Plexiglas head cradle just to the left of the Plexiglas head cradle just to the left of the person's head. The 1.5 cm diameter the person's head. The 1.5 cm diameter reference tube was positioned so its length reference tube was positioned so its length ran axially, spanning the sensitive region ran axially, spanning the sensitive region of the of the 31 31 P radio frequency coil. Transmit/ P radio frequency coil. Transmit/ receive frequency was centred on phosphoreceive frequency was centred on phosphocreatine, as measured with a global free creatine, as measured with a global free induction decay. Tip angle, optimised induction decay. Tip angle, optimised for the phosphomonoester/phosphodiester for the phosphomonoester/phosphodiester resonances at a 500 ms repetition time, resonances at a 500 ms repetition time, was 32 was 328 8. . In vivo
In vivo 31 31 P-MRS used an opti-P-MRS used an optimised three-dimensional chemical shift mised three-dimensional chemical shift imaging sequence (Jensen imaging sequence (Jensen et al et al, 2002 , 2002a a): ): repetition time 500 ms; sampling bandrepetition time 500 ms; sampling bandwidth width + +2 kHz; complex points 1600; read-2 kHz; complex points 1600; readout duration 400 ms; pre-pulses 20; receiver out duration 400 ms; pre-pulses 20; receiver gain 94 dB; pre-acquisition delay 1.905 ms; gain 94 dB; pre-acquisition delay 1.905 ms; field of view ( field of view (x x, ,y y, ,z z) 280 mm; nominal ) 280 mm; nominal volume 5.4 cm volume 5.4 cm 3 3 ; maximum phase-encode ; maximum phase-encode matrix dimension ( matrix dimension (x x, ,y y, ,z z) 14 ) 146 614 146 614 14 (zero-filled out to 16 (zero-filled out to 166 616 166 616 prior to 16 prior to reconstruction). The three-dimensional reconstruction). The three-dimensional chemical shift imaging sequence used a chemical shift imaging sequence used a reduced phase-encoding scheme allowing reduced phase-encoding scheme allowing for the inclusion of spherically bound, for the inclusion of spherically bound, reduced point, weighted reduced point, weighted k k-space acquisi--space acquisition, providing approximately 40% more tion, providing approximately 40% more signal-to-noise for a given scan time and signal-to-noise for a given scan time and effective voxel volume over conventional effective voxel volume over conventional methods (Jensen methods (Jensen et al et al, 2002 , 2002b . ).
In vivo
In vivo post-processing and spectral post-processing and spectral analysis analysis All All in vivo in vivo chemical shift imaging/image chemical shift imaging/image data were processed and viewed using data were processed and viewed using Varian Nuclear Magnetic Resonance softVarian Nuclear Magnetic Resonance software (version 6.1B) and software designed ware (version 6.1B) and software designed and written on site. Prior to fast Fourier and written on site. Prior to fast Fourier transform reconstruction to spatially transform reconstruction to spatially resolve the chemical shift imaging spectra, resolve the chemical shift imaging spectra, the collected the collected k k-space data were centred in -space data were centred in a 16 a 166 616 166 616 cubic matrix. Each time-16 cubic matrix. Each timedomain free induction decay was then domain free induction decay was then zero-filled out to 2048 complex points zero-filled out to 2048 complex points and left-shifted 5 points to remove residual and left-shifted 5 points to remove residual bone and rigid membrane signal. bone and rigid membrane signal.
Using the Using the 1 1 H images, the three-H images, the threedimensional chemical shift imaging data dimensional chemical shift imaging data grid was shifted in the grid was shifted in the x x, , y y and and z z dimendimensions in order to position each voxel in sions in order to position each voxel in the appropriate the appropriate 31 31 P region of interest. For P region of interest. For all brains examined, the Brodmann area all brains examined, the Brodmann area and Talairach coordinates for voxel centres and Talairach coordinates for voxel centres ( (x x, ,y y, ,z z) were evaluated for every ) were evaluated for every 31 31 P region P region of interest using statistical parametric mapof interest using statistical parametric mapping (Table 2) . Partial overlap with adjaping (Table 2) . Partial overlap with adjacent structures was unavoidable in many cent structures was unavoidable in many of the regions owing to voxel volume and of the regions owing to voxel volume and shape (Fig. 1) . shape (Fig. 1) .
All All in vivo in vivo spectra were fitted in the spectra were fitted in the time domain using a non-linear, iterative time domain using a non-linear, iterative fitting program developed on site (Fig. 2) . fitting program developed on site (Fig. 2) . The fitting routine is based on the The fitting routine is based on the Marquardt-Levenberg algorithm, using Marquardt-Levenberg algorithm, using prior spectral knowledge for the relative prior spectral knowledge for the relative amplitudes, line widths, line shapes, peak amplitudes, line widths, line shapes, peak positions and J-coupling constants to model positions and J-coupling constants to model the the in vivo in vivo 31 31 P brain spectrum (Jensen P brain spectrum (Jensen et al et al, , 2002 (Jensen et al et al, , 2002a . Since it was positioned along the ). Since it was positioned along the inner face of the coil, the reference standard inner face of the coil, the reference standard was subject to different radio frequency was subject to different radio frequency power from that used for the brain, and power from that used for the brain, and was volume-bound by the was volume-bound by the x x and and y y tube tube dimensions (1.5 cm diameter), both requirdimensions (1.5 cm diameter), both requiring correction. Therefore, the methylene ing correction. Therefore, the methylene diphosphonic acid reference area, modelled diphosphonic acid reference area, modelled with a triplet structure, was corrected for with a triplet structure, was corrected for (Jensen et al et al, 2002 , 2002a a). The fitted metabolite ampli-). The fitted metabolite amplitudes are not tudes are not T T 2 2 -weighted since the fitting -weighted since the fitting algorithm extrapolates back to time zero. algorithm extrapolates back to time zero. Each Each 31 31 P metabolite value was finally cor-P metabolite value was finally corrected for cerebrospinal fluid partial volume rected for cerebrospinal fluid partial volume fraction assuming phosphate concentration fraction assuming phosphate concentration in cerebrospinal fluid to be negligible. There in cerebrospinal fluid to be negligible. There was no correction for the ratio of grey to was no correction for the ratio of grey to white matter. white matter.
Statistics Statistics
Statistical calculations were performed Statistical calculations were performed using the Statistical Package for the Social using the Statistical Package for the Social Sciences, version 10.0 for Windows. A Sciences, version 10.0 for Windows. A two-tailed two-tailed t t-test was used to test for signif--test was used to test for significant differences in age, parental education, icant differences in age, parental education, grey matter, white matter and cerebrospinal grey matter, white matter and cerebrospinal fluid partial volumes between groups fluid partial volumes between groups ( (P P5 50.05). In the same fashion as in our 0.05). In the same fashion as in our previous study (Jensen previous study (Jensen et al et al, 2002 (Jensen et al et al, , 2002b , statis-), statistical treatment of all ten tical treatment of all ten 31 31 P metabolite P metabolite ratios for each region first involved a oneratios for each region first involved a onefactor multivariate analysis of variance factor multivariate analysis of variance (MANOVA) with a between-subjects factor (MANOVA) with a between-subjects factor of group. Pursuant to a significant multiof group. Pursuant to a significant multivariate test, univariate variate test, univariate F F-tests were used to -tests were used to examine group differences, with examine group differences, with a a set at set at P P5 50.05. In each region where significant 0.05. In each region where significant group differences in group differences in 31 31 P metabolites were P metabolites were found, Pearson correlations ( found, Pearson correlations (P P5 50.01) were 0.01) were computed within the patient group between computed within the patient group between 31 31 P metabolite levels and each of the follow-P metabolite levels and each of the following variables: SANS and SAPS scores, ing variables: SANS and SAPS scores, age, parental education and duration of age, parental education and duration of untreated psychosis. untreated psychosis.
Our application of the region-wise Our application of the region-wise MANOVA represents an optimal com-MANOVA represents an optimal compromise between power and type I error promise between power and type I error protection. Expanding the analysis to protection. Expanding the analysis to include region as a within-subject factor, include region as a within-subject factor, resulting in the split-plot factorial MANOresulting in the split-plot factorial MANO-VA applied to the vector of the metabolites, VA applied to the vector of the metabolites, unnecessarily complicates the analysis unnecessarily complicates the analysis when there are when there are a priori a priori reasons to select reasons to select the targeted regions (Stevens, 1996) . The the targeted regions (Stevens, 1996) . The issue of following up a significant issue of following up a significant MANOVA test, and whether or not to MANOVA test, and whether or not to 4 11 4 11 apply Bonferroni correction, has been adapply Bonferroni correction, has been addressed in the literature (Hummel & Sligo, dressed in the literature (Hummel & Sligo, 1971; Stevens, 1996) , justifying the statisti-1971; Stevens, 1996) , justifying the statistical treatment of our data. cal treatment of our data.
RESULTS RESULTS
No significant difference was found in age, No significant difference was found in age, parental education or grey matter voxel parental education or grey matter voxel tissue partial volumes in any region betissue partial volumes in any region between groups. Cerebrospinal fluid partial tween groups. Cerebrospinal fluid partial volume fraction was significantly greater volume fraction was significantly greater in the anterior cingulate of people in the in the anterior cingulate of people in the schizophrenia group ( schizophrenia group (P P5 50.01), and the 0.01), and the white matter partial volume fraction was white matter partial volume fraction was lower in the right prefrontal cortex in this lower in the right prefrontal cortex in this group ( group (P P5 50.05) ( Table 3 ). The MANOVA 0.05) ( 
DISCUSSION DISCUSSION
Unlike patients with chronic schizophrenia, Unlike patients with chronic schizophrenia, people with first-episode illness show people with first-episode illness show increased levels of phosphodiester (glyincreased levels of phosphodiester (glycerophosphocholine) and high-energy cerophosphocholine) and high-energy phosphates (inorganic phosphate, phosphophosphates (inorganic phosphate, phosphocreatine and adenosine triphosphate) in the creatine and adenosine triphosphate) in the anterior cingulate, suggesting accelerated anterior cingulate, suggesting accelerated membrane breakdown and aberrant energy membrane breakdown and aberrant energy metabolism in this region. It is unlikely that metabolism in this region. It is unlikely that these changes are related to medication, as these changes are related to medication, as most of the people investigated had not most of the people investigated had not been exposed to neuroleptics. It is also very been exposed to neuroleptics. It is also very unlikely that partial-volume tissue differunlikely that partial-volume tissue differences contribute to these findings, since ences contribute to these findings, since the measured metabolite levels were the measured metabolite levels were corrected for cerebrospinal fluid partial corrected for cerebrospinal fluid partial volume fraction, and no significant differvolume fraction, and no significant difference was found in the grey matter or white ence was found in the grey matter or white matter fractions in any region where metamatter fractions in any region where metabolite levels differed between groups. The bolite levels differed between groups. The regional distribution of change in phosphoregional distribution of change in phospholipid levels seen in this study of first-episode lipid levels seen in this study of first-episode patients is extremely selective, being patients is extremely selective, being restricted to the anterior cingulate. Interestrestricted to the anterior cingulate. Interestingly, in our earlier study of patients with ingly, in our earlier study of patients with chronic disease (Jensen chronic disease (Jensen et al et al, 2002 (Jensen et al et al, , 2002b , one ), one of the more profound alterations in phosof the more profound alterations in phospholipid levels was also seen in this region. pholipid levels was also seen in this region.
Interpretation of these findings could Interpretation of these findings could lead to several conclusions pertaining to lead to several conclusions pertaining to how symptoms of schizophrenia develop how symptoms of schizophrenia develop and evolve over time. One possible and evolve over time. One possible explanation might be that the onset of psyexplanation might be that the onset of psychosis as an acute, identifiable event is in chosis as an acute, identifiable event is in 4 12 4 12 PCho, phosphocholine; PCr, phosphocreatine; PDE, phosphodiester; PEtn, phosphoethanolamine; P PCho, phosphocholine; PCr, phosphocreatine; PDE, phosphodiester; PEtn, phosphoethanolamine; P i i , inorganic , inorganic phosphate; PME, phosphomonoester; ppm, parts per million; MP, membrane phospholipids. phosphate; PME, phosphomonoester; ppm, parts per million; MP, membrane phospholipids. (18) 23 (18) 19 (16) 19 (16) 74 (23) 74 (23) 79 (16) 79 (16) 4 (7) 4 (7) 2 (1) 2 (1) Right hippocampus Right hippocampus 21 (17) 21 (17) 22 (17) 22 (17) 77 (19) 77 (19) 77 (17) 77 (17) 2 (4) 2 (4) 1 (1) 1 (1) Left prefrontal Left prefrontal 38 (12) 38 (12) 35 (8) 35 (8) 52 (20) 52 (20) 62 (10) 62 (10) 10 (18) 10 (18) 3 (4) 3 (4) Right prefrontal Right prefrontal 42 (21) 42 (21) 33 (9) 33 (9) 45 (27) 45 (27) 65 (9) 65 (9) 13 (21) 13 (21) 2 (3) 2 (3) fact a process that continues over an fact a process that continues over an extended period. The initial excitatory extended period. The initial excitatory pathophysiological processes involved in pathophysiological processes involved in the onset of psychosis may continue in the the onset of psychosis may continue in the anterior cingulate, while the degenerative anterior cingulate, while the degenerative process continues in other regions such as process continues in other regions such as the thalamus or hippocampus, which may the thalamus or hippocampus, which may have already been damaged early in brain have already been damaged early in brain development. Eventually, in the chronic development. Eventually, in the chronic stages of illness, the anterior cingulate stages of illness, the anterior cingulate experiences so much neurodegeneration that experiences so much neurodegeneration that its phospholipid profile resembles that of the its phospholipid profile resembles that of the neurally damaged thalamus, as we observed neurally damaged thalamus, as we observed in our study of patients with chronic schizoin our study of patients with chronic schizophrenia (Jensen phrenia (Jensen et al et al 2002 (Jensen et al et al 2002b , and is consis-), and is consistent with early neurodevelopmental lesions tent with early neurodevelopmental lesions suggested in these regions (Lipska & suggested in these regions (Lipska & Weinberger, 1993; Jones, 1997; Andreasen, Weinberger, 1993; Jones, 1997; Andreasen, 1999) . Also, this suggested neurodegenera-1999). Also, this suggested neurodegenerative process fits with the finding of increased tive process fits with the finding of increased glutamate-mediated metabolites with glutamate-mediated metabolites with this region seen in patients with first-episode this region seen in patients with first-episode disease compared with controls. However, disease compared with controls. However, since we are looking at the same metabolites since we are looking at the same metabolites at two discrete time points in different study at two discrete time points in different study groups, the question remains whether the groups, the question remains whether the hypothetical neurodevelopmental changes hypothetical neurodevelopmental changes in regions such as the thalamus, hippocamin regions such as the thalamus, hippocampus or cerebellum are, in fact, a prerequisite pus or cerebellum are, in fact, a prerequisite for putative degenerative changes in regions for putative degenerative changes in regions such as the cingulate. More longitudinal such as the cingulate. More longitudinal human research studies in schizophrenia human research studies in schizophrenia are needed to support the neuroare needed to support the neurodevelopmental/degenerative model of developmental/degenerative model of schizophrenia. schizophrenia.
Implications of altered Implications of altered phosphodiester levels phosphodiester levels
Phospholipase A1 and A2 activity produces Phospholipase A1 and A2 activity produces the phosphodiester metabolites glycerothe phosphodiester metabolites glycerophosphocholine and glycerophosphophosphocholine and glycerophosphoethanolamine. Phosphodiesterase, a catalytic ethanolamine. Phosphodiesterase, a catalytic enzyme responsible for the breakdown of enzyme responsible for the breakdown of phospholipid membrane, also produces phospholipid membrane, also produces glycerophosphocholine and glycerophosglycerophosphocholine and glycerophosphoethanolamine. A decrease in the phoethanolamine. A decrease in the activity of this enzyme, and/or an increase activity of this enzyme, and/or an increase in phospholipase A1 and A2 activity, can in phospholipase A1 and A2 activity, can decrease phosphodiester levels in the brain, decrease phosphodiester levels in the brain, and may be involved in the development of and may be involved in the development of schizophrenia (Horrobin schizophrenia (Horrobin et al et al, 1994) . How-, 1994) . However, the increase in glycerophosphocholine ever, the increase in glycerophosphocholine seen in the anterior cingulate may suggest a seen in the anterior cingulate may suggest a reversal of this mechanism, leading to reversal of this mechanism, leading to increased membrane breakdown during increased membrane breakdown during the acute stages of the illness and eventual the acute stages of the illness and eventual neuronal loss in this region as the illness neuronal loss in this region as the illness progresses. This is supported by our earlier progresses. This is supported by our earlier study in patients with chronic illness at study in patients with chronic illness at 4.0 Tesla (Jensen 4.0 Tesla (Jensen et al et al, 2002 (Jensen et al et al, , 2002b , which found ), which found decreased glycerophosphoethanolamine decreased glycerophosphoethanolamine levels in the anterior cingulate. Interestlevels in the anterior cingulate. Interestingly, no difference in any phospholipid ingly, no difference in any phospholipid metabolite was detected between groups metabolite was detected between groups in either the left or the right prefrontal in either the left or the right prefrontal cortex between the first-episode schizocortex between the first-episode schizophrenia group and the controls. This phrenia group and the controls. This contrasts with the results of other studies, contrasts with the results of other studies, which report increased prefrontal phosphowhich report increased prefrontal phosphodiester levels in first-episode but not diester levels in first-episode but not chronic illness (Williamson & Drost, chronic illness (Williamson & Drost, 1999) and decreased phosphodiester levels 1999) and decreased phosphodiester levels in drug-naıve (not first-episode) patients in in drug-naïve (not first-episode) patients in the left frontal lobe (Yacubian the left frontal lobe (Yacubian et al et al, , 2002 ). However, these earlier studies were 2002). However, these earlier studies were conducted at lower field strengths ( conducted at lower field strengths (5 52 2 Tesla), where (unlike 4.0 Tesla imaging) Tesla), where (unlike 4.0 Tesla imaging) the broad phosphodiester resonance is the broad phosphodiester resonance is dominant in the human dominant in the human 31 31 P brain spectrum. P brain spectrum. This fact, combined with different voxel This fact, combined with different voxel volumes and analytical techniques might volumes and analytical techniques might possibly contribute to our different findings possibly contribute to our different findings regarding the prefrontal cortex. Our regarding the prefrontal cortex. Our 31 31 P-P-MRS studies of the brains of patients with MRS studies of the brains of patients with chronic and first-episode schizophrenia at chronic and first-episode schizophrenia at 4.0 Tesla suggest that the prefrontal cortex 4.0 Tesla suggest that the prefrontal cortex may manifest abnormalities in phosphomay manifest abnormalities in phospholipid metabolism only later in the chronic lipid metabolism only later in the chronic stages of illness, suggestive of eventual stages of illness, suggestive of eventual neurodegeneration. Indeed, if neuroneurodegeneration. Indeed, if neurodegeneration is the primary course of degeneration is the primary course of evolution in this illness, then one could evolution in this illness, then one could speculate that early intervention with speculate that early intervention with neuroprotective agents could halt -or at neuroprotective agents could halt -or at least slow down -the onset and developleast slow down -the onset and development of schizophrenic symptoms, lessening ment of schizophrenic symptoms, lessening the negative social, physical and economic the negative social, physical and economic impact of this disease. impact of this disease.
Other metabolites Other metabolites
High-energy phosphate changes seen in High-energy phosphate changes seen in this study of first-episode schizophrenia this study of first-episode schizophrenia 4 13 4 13 , 1998) . Since schizophrenia has a strong 1998). Since schizophrenia has a strong genetic component, mitochondrial dysfuncgenetic component, mitochondrial dysfunction could at least partially explain the tion could at least partially explain the energetic anomalies seen in this and other energetic anomalies seen in this and other 31 31 P-MRS studies of schizophrenia (Jensen P-MRS studies of schizophrenia (Jensen et al et al, 2002 (Jensen et al et al, , 2002b . However, this hypothesis ). However, this hypothesis has yet to be tested. has yet to be tested.
Effect of medication Effect of medication
The effects of neuroleptic and anxiolytic The effects of neuroleptic and anxiolytic medications on brain phosphorus metabomedications on brain phosphorus metabolites warrant further discussion. Two lites warrant further discussion. Two human studies human studies in vivo in vivo examining the effect examining the effect of neuroleptic administration on phosof neuroleptic administration on phosphorus metabolites suggest that phosphophorus metabolites suggest that phosphodiester levels are decreased in the diester levels are decreased in the temporal lobe (Fukuzako temporal lobe (Fukuzako et al et al, 1999) and , 1999 ) and increased in the frontal lobe (Volz increased in the frontal lobe (Volz et al et al, , 1999 ) with neuroleptic medication. In this 1999) with neuroleptic medication. In this study, we observed no differences in phosstudy, we observed no differences in phosphodiester levels in either of these regions phodiester levels in either of these regions between groups. However, it cannot be between groups. However, it cannot be ruled out that phosphodiester level differruled out that phosphodiester level differences in these regions do actually exist, ences in these regions do actually exist, but are masked by the effects of neurobut are masked by the effects of neuroleptics. There are very few studies examleptics. There are very few studies examining the effects of benzodiazepine ining the effects of benzodiazepine medications on brain phosphorus levels. A medications on brain phosphorus levels. A study by Miranda study by Miranda et al et al (1990) found that (1990) found that phosphocreatine utilisation is altered in phosphocreatine utilisation is altered in the adult rat brain only after the adult rat brain only after in utero in utero expoexposure to benzodiazepine ligands. Extrapolatsure to benzodiazepine ligands. Extrapolating this result to the humans investigated in ing this result to the humans investigated in this study, one can only speculate that this study, one can only speculate that phosphocreatine levels might be affected phosphocreatine levels might be affected by maternal use of benzodiazepines during by maternal use of benzodiazepines during pregnancy. However, it is clear that more pregnancy. However, it is clear that more human research is needed in this area to test human research is needed in this area to test this hypothesis. this hypothesis.
Spectroscopy limitations Spectroscopy limitations
The repetition time used for our The repetition time used for our 31 31 P-MRS P-MRS acquisition (500 ms) was very short comacquisition (500 ms) was very short compared with the measured pared with the measured T T 1 1 values of the values of the phosphorus metabolites. The resulting phosphorus metabolites. The resulting 31 31 P P spectra are therefore spectra are therefore T T 1 1 -weighted despite -weighted despite radio frequency pulsing at the Ernst angle radio frequency pulsing at the Ernst angle for a for a T T 1 1 of 3 s (the average of 3 s (the average T T 1 1 of phosphoof phosphomonoester, phosphodiester and phosphomonoester, phosphodiester and phosphocreatine metabolites). It is possible that creatine metabolites). It is possible that our observed changes in metabolite levels our observed changes in metabolite levels between groups might partly result from between groups might partly result from different different T T 1 1 values in the affected regions, values in the affected regions, aside from concentration differences. This aside from concentration differences. This is unlikely, however, since is unlikely, however, since T T 1 1 values in values in people with schizophrenia would have to people with schizophrenia would have to differ by up to several hundred per cent in differ by up to several hundred per cent in order to equalise the metabolite ratios order to equalise the metabolite ratios between the groups, and there is no between the groups, and there is no 
